Anticonvulsant effect of 5-ethyl, 5-phenyl, 2-pyrrolidinone and its possible relationship to gamma-aminobutyric acid-dependent inhibitory mechanisms.
D000470:Alkaloids / Q000037:antagonists & inhibitors; D000613:Aminobutyrates / Q000378:metabolism*; D000818:Animals; D000927:Anticonvulsants / Q000494:pharmacology*; D004149:Dioxoles / Q000037:antagonists & inhibitors; D006835:Hydrazones / Q000037:antagonists & inhibitors; D007546:Isoquinolines / Q000037:antagonists & inhibitors; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D010433:Pentylenetetrazole / Q000037:antagonists & inhibitors; D010672:Phenytoin / Q000494:pharmacology; D011732:Pyridoxal Phosphate / Q000037:antagonists & inhibitors; D011760:Pyrrolidinones / Q000494:pharmacology*; D012640:Seizures / Q000139:chemically induced; D012663:Semicarbazides / Q000037:antagonists & inhibitors; D013331:Strychnine / Q000037:antagonists & inhibitors; D013871:Thiones / Q000037:antagonists & inhibitors; D013997:Time Factors
D000470:Alkaloids; D000613:Aminobutyrates; D000927:Anticonvulsants; D004149:Dioxoles; D006835:Hydrazones; D007546:Isoquinolines; D011760:Pyrrolidinones; D012663:Semicarbazides; D013871:Thiones; D011732:Pyridoxal Phosphate; D010672:Phenytoin; D013331:Strychnine; D010433:Pentylenetetrazole